Judy‐Anne W. Chapman

NCIC-CTG MA.20: An intergroup trial of regional nodal irradiation in early breast cancer.

Timothy J. Whelan, Ivo A. Olivotto, Ida Ackerman et al. · Journal of Clinical Oncology · 2011 · 241 citations

Medicine, Oncology, Radiation Oncology +17

Assessment of the prognostic and predictive utility of the Breast Cancer Index (BCI): an NCIC CTG MA.14 study

Dennis C. Sgroi, Judy‐Anne W. Chapman, Tanja Badovinac-Črnjević et al. · Breast Cancer Research · 2016 · 72 citations · Full text

Medicine, Oncology, Breast Oncology +15

Open-label phase III randomized controlled trial comparing taxane-based chemotherapy (Tax) with lapatinib (L) or trastuzumab (T) as first-line therapy for women with HER2+ metastatic breast cancer: Interim analysis (IA) of NCIC CTG MA.31/GSK EGF 108919.

Karen A. Gelmon, Frances Boyle, Bella Kaufman et al. · Journal of Clinical Oncology · 2012 · 68 citations

Medicine, Oncology, Pharmacology +17

Biological Significance of Occult Micrometastases in Histologically Negative Axillary Lymph Nodes in Breast Cancer Patients Using the Recent American Joint Committee on Cancer Breast Cancer Staging System

Harriette J. Kahn, Wedad Hanna, Judy‐Anne W. Chapman et al. · The Breast Journal · 2006 · 64 citations

Medicine, Oncology, Pathology +17

Immunohistochemical Assessment of Expression of Centromere Protein—A (CENPA) in Human Invasive Breast Cancer

Ashish Rajput, Nianping Hu, Sonal Varma et al. · Cancers · 2011 · 55 citations · Full text

Life Sciences, Molecular Biology, Oncology +17